Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe

Trial Profile

Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2015

At a glance

  • Drugs Atazanavir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 05 Jan 2015 Last checked against ClinicalTrials.gov record.
    • 26 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Sep 2011 Additional locations identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top